PCA3 represents a clinically meaningful predictor of prostate cancer at repeat biopsy
Haese, A Chun, F De La Taille, A Van Poppel, Hendrik Marberger, M Mulders, P Abbou, C. C Stenzl, A Huland, H Tinzi, M Remzi, M Feyeralbend, S Van Gils, M Stillebroer, A Schalken, J #
Elsevier science bv
European urology supplements vol:7 issue:3 pages:140-140
EAU location:Berlin date:March 2008
Introduction & Objectives: The urinary prostate cancer 3 (PCA 3) marker represents a hopeful novel polecular marker to improve specificity of prostate cancer detection. We investigated for the first time whether the urinary prostate cancer 3 (PCA 3) marker is capable to withstand morst stringent uni- and multivariable analyses to display its discriminative as well as its informative character.